TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis.
作者： Changfeng Li , Yongjian Gao , Yongchao Li , Dayong Ding
DOI: 10.1016/J.BBRC.2017.03.042
关键词:
摘要: … (A) MTX resistant tumors were subject to q-PCR for detecting the correlation between miR-186 level and CPEB2 level. (B) HEK293T cells were transfected with miR-186 with or without …
sci-hub.se 参考文章(28)
Jiemei Tan, Kaifeng Qiu, Mingyi Li, Ying Liang, Double‐negative feedback loop between long non‐coding RNA TUG1 and miR‐145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells FEBS Letters. ,vol. 589, pp. 3175- 3181 ,(2015) , 10.1016/J.FEBSLET.2015.08.020
Heng Cai, Yixue Xue, Ping Wang, Zhenhua Wang, Zhen Li, Yi Hu, Zhiqing Li, Xiuli Shang, Yunhui Liu, The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget. ,vol. 6, pp. 19759- 19779 ,(2015) , 10.18632/ONCOTARGET.4331
J. E. Wilusz, H. Sunwoo, D. L. Spector, Long noncoding RNAs: functional surprises from the RNA world Genes & Development. ,vol. 23, pp. 1494- 1504 ,(2009) , 10.1101/GAD.1800909
Joshua N Mirkin, Peter B Bach, Human papillomavirus vaccine coverage – Author's reply The Lancet. ,vol. 376, pp. 330- ,(2010) , 10.1016/S0140-6736(10)61181-6
Jeffrey A. Meyerhardt, Robert J. Mayer, Systemic Therapy for Colorectal Cancer The New England Journal of Medicine. ,vol. 352, pp. 476- 487 ,(2005) , 10.1056/NEJMRA040958
Tim R Mercer, John S Mattick, Structure and function of long noncoding RNAs in epigenetic regulation Nature Structural & Molecular Biology. ,vol. 20, pp. 300- 307 ,(2013) , 10.1038/NSMB.2480
Jim Cassidy, Stephen Clarke, Eduardo Díaz-Rubio, Werner Scheithauer, Arie Figer, Ralph Wong, Sheryl Koski, Mikhail Lichinitser, Tsai-Shen Yang, Fernando Rivera, Felix Couture, Florin Sirzén, Leonard Saltz, Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 26, pp. 2006- 2012 ,(2008) , 10.1200/JCO.2007.14.9898
I-Ming Kuo, Song-Fong Huang, Jy-Ming Chiang, Chien-Yuh Yeh, Kun-Ming Chan, Jinn-Shiun Chen, Ming-Chin Yu, Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis World Journal of Surgical Oncology. ,vol. 13, pp. 92- 92 ,(2015) , 10.1186/S12957-015-0497-6
Jolien Tol, Miriam Koopman, Annemieke Cats, Cees J. Rodenburg, Geert J.M. Creemers, Jolanda G. Schrama, Frans L.G. Erdkamp, Allert H. Vos, Cees J. van Groeningen, Harm A.M. Sinnige, Dirk J. Richel, Emile E. Voest, Jeroen R. Dijkstra, Marianne E. Vink-Börger, Ninja F. Antonini, Linda Mol, Johan H.J.M. van Krieken, Otilia Dalesio, Cornelis J.A. Punt, Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer The New England Journal of Medicine. ,vol. 360, pp. 563- 572 ,(2009) , 10.1056/NEJMOA0808268
Bernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, Graeme J Poston, Peter M Schlag, Philippe Rougier, Wolf O Bechstein, John N Primrose, Euan T Walpole, Meg Finch-Jones, Daniel Jaeck, Darius Mirza, Rowan W Parks, Laurence Collette, Michel Praet, Ullrich Bethe, Eric Van Cutsem, Werner Scheithauer, Thomas Gruenberger, None, Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial The Lancet. ,vol. 371, pp. 1007- 1016 ,(2008) , 10.1016/S0140-6736(08)60455-9